Laura Hix Glickman

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter et al. · Cell Reports · 2015 · 1.5K citations · Full text

Medicine, Immunology, Oncology +17

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 700 citations

Medicine, Oncology, Pharmacology +16

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 438 citations · Full text

Life Sciences, Immunology, Oncology +17

Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer

Heather Kinkead, Alexander C. Hopkins, Eric R. Lutz et al. · JCI Insight · 2018 · 162 citations · Full text

Life Sciences, Immunology, Oncology +17

NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice

Madhavi Puchalapalli, Xianke Zeng, Liang Mu et al. · PLoS ONE · 2016 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +15